These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13987883)

  • 21. [ON THE STABILITY OF CENTRAL EUROPEAN ENCEPHALITIS VIRUS (CEE) IN PHOSPHATE AND TRIS BUFFER SOLUTIONS].
    BLOEDHORN H
    Zentralbl Bakteriol Orig; 1963 Oct; 190():149-63. PubMed ID: 14119875
    [No Abstract]   [Full Text] [Related]  

  • 22. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
    Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
    J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on Japanese B encephalitis virus vaccines from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. 2. The characteristics of inactivation of an attenuated strain of OCT-541.
    Darwish MA; Hammon WM
    J Immunol; 1966 May; 96(5):806-13. PubMed ID: 4288022
    [No Abstract]   [Full Text] [Related]  

  • 24. [Changes in the sensitivity of the body to heterologous viral infections following immunization with different virus vaccines. I. The ability of live polio vaccine and tick-borne encephalitis vaccine to evoke resistance to heterologous viral infections].
    Gorshunova LP; Nabokova AV
    Br J Soc Clin Psychol; 1970 Dec; 9(4):83-6. PubMed ID: 5494794
    [No Abstract]   [Full Text] [Related]  

  • 25. [Research on the tick-borne encephalitis; I. Biology of the tick-borne encephalitis viral strains isolated in Poland].
    PRZESMYCKI F; TAYTSCH Z; SEMKOW R; WALENTYNOWICZ-STANCZYK
    Przegl Epidemiol; 1954; 8(3):205-14. PubMed ID: 13224769
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus.
    Morozova OV; Bakhvalova VN; Potapova OF; Grishechkin AE; Isaeva EI; Aldarov KV; Klinov DV; Vorovich MF
    Vaccine; 2014 May; 32(25):3101-6. PubMed ID: 24631082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. THE ROLE OF INTERFERON IN TICK-BORNE ENCEPHALITIS VIRUS-INFECTED L CELLS. II. PERSISTENT INFECTION.
    STANCEK D; VILCEK J
    Acta Virol; 1965 Jan; 9():9-17. PubMed ID: 14299366
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on Japanese B encephalitis virus vaccine from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. 4. Preparation and characterization of vaccine lot for human trial.
    Darwish MA; Hammon WM
    Am J Trop Med Hyg; 1966 Sep; 15(5):765-8. PubMed ID: 4288193
    [No Abstract]   [Full Text] [Related]  

  • 30. [Isohemolysis with the virus of tick-borne encephalitis].
    JETTMAR HM
    Z Hyg Infektionskr; 1957; 143(4):355-63. PubMed ID: 13434262
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on preparation of a tick-borne encephalitis (TBE) vaccine from the Skalica strain.
    Gresíková M; Sekeyová M; Marcinka K; Ciampor F
    Acta Virol; 1986 May; 30(3):243-8. PubMed ID: 2874729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Donor immunization with an inactivated concentrated purified vaccine against tick-borne encephalitis to obtain immune blood preparations].
    El'bert LB; Pervikov IuV; Grachev VP; Rusanov VM; Krokhina MA
    Vopr Virusol; 1984; 29(1):56-9. PubMed ID: 6608828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on Japanese B encephalitis virus vaccines from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. (1). Obtaining maximum titers of virus using an attenuated strain of OCT-541.
    Darwish MA; Hammon WM
    J Immunol; 1966 Apr; 96(4):691-8. PubMed ID: 4287081
    [No Abstract]   [Full Text] [Related]  

  • 34. NATURE OF THE HEMAGGLUTINATING ACTIVITY OF TICK-BORNE ENCEPHALITIS VIRUS.
    SEMENOV BF; REZEPOVA AI
    Fed Proc Transl Suppl; 1965; 24():266-8. PubMed ID: 14304761
    [No Abstract]   [Full Text] [Related]  

  • 35. CULTIVATION OF TICK-BORNE ENCEPHALITS VIRUS IN REPTILE TISSUE CULTURES.
    SOMOGYIOVA J; REHACEK J
    Acta Virol; 1965 May; 9():286. PubMed ID: 14328231
    [No Abstract]   [Full Text] [Related]  

  • 36. [Virus of Czechoslovakian tick-borne encephalitis in chick embryo. II].
    SLONIM D
    Cesk Epidemiol Mikrobiol Imunol; 1956 Mar; 5(1):3-13. PubMed ID: 13364967
    [No Abstract]   [Full Text] [Related]  

  • 37. [Interaction between tick-borne encephalitis virus and diploid cells].
    Semenov BF; Karaseva PS; Rapoport RI
    Vopr Virusol; 1966; 11(1):17-21. PubMed ID: 5974413
    [No Abstract]   [Full Text] [Related]  

  • 38. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vaccination against tick-borne encephalitis using an inactivated vaccine].
    Duniewicz M; Markvart K; Vlasimská H; Heinz F; Kulková H
    Cas Lek Cesk; 1983 Aug; 122(32-33):1000-2. PubMed ID: 6627307
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on Japanese B encephalitis virus vaccines from tissue culture. 8. Formalin inactivated OCT-wild strain vaccine.
    Darwish MA; Hammon WM
    J Immunol; 1966 Oct; 97(4):506-11. PubMed ID: 4289222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.